Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/2382| Title: | Cellular therapies in a private hospital setting: a single centre Australian experience. |
| Epworth Authors: | Benemerito, M. Sharlyn Tan, Charmaine Bayly-McCredie, Elena |
| Keywords: | Autologous Stem Cell Transplantation ASCT Chimeric Antigen Receptor T Cell CAR T Cell Myeloma Lymphoma Haematology Immunotherapies Cancer Services Clinical Institute Epworth HealthCare, Victoria, Australia. |
| Issue Date: | Aug-2025 |
| Conference Name: | Epworth HealthCare Research Week 2025 |
| Conference Location: | Epworth Research Institute, Victoria, Australia |
| Abstract: | Autologous stem cell transplantation (ASCT) and chimeric antigen receptor T cell (CAR T cell) therapy are now key treatments for myeloma and lymphoma in Australia. In early 2023, Epworth HealthCare established ASCT becoming the first private hospital in Victoria to offer this service. Epworth HealthCare currently provides ASCT as standard care and CAR T therapy through clinical trials. |
| URI: | http://hdl.handle.net/11434/2382 |
| Type: | Conference Poster |
| Type of Clinical Study or Trial: | Retrospective studies |
| Appears in Collections: | Research Week |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Cell therapies poster_Sharlyn Benemerito.pdf | 221.84 kB | Adobe PDF |  View/Open |
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.